Bristol-Myers Squibb Company
Antibodies conjugatable by transglutaminase and conjugates made therefrom
Last updated:
Abstract:
An antibody has at a heavy chain thereof a C-terminal extension that includes at least one glutamine that is a substrate for transglutaminase, enabling the transglutaminase-mediated preparation antibody-drug conjugates using such antibody.
Status:
Grant
Type:
Utility
Filling date:
1 Mar 2016
Issue date:
9 Jun 2020